Oncolytic virus M1 is a promising anticancer agent; however, its therapeutic efficacy is often limited by insufficient intratumoral viral replication and host antiviral immunity. Sirolimus, an mTOR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results